10.24
price down icon3.40%   -0.36
after-market After Hours: 10.24
loading
Organon Co stock is traded at $10.24, with a volume of 4.04M. It is down -3.40% in the last 24 hours and down -2.20% over the past month. Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
See More
Previous Close:
$10.60
Open:
$10.69
24h Volume:
4.04M
Relative Volume:
1.01
Market Cap:
$2.66B
Revenue:
$6.29B
Net Income/Loss:
$750.00M
P/E Ratio:
3.5556
EPS:
2.88
Net Cash Flow:
$586.00M
1W Performance:
-6.82%
1M Performance:
-2.20%
6M Performance:
-12.10%
1Y Performance:
-43.43%
1-Day Range:
Value
$10.21
$10.77
1-Week Range:
Value
$10.21
$11.29
52-Week Range:
Value
$8.01
$19.05

Organon Co Stock (OGN) Company Profile

Name
Name
Organon Co
Name
Phone
551-430-6000
Name
Address
30 HUDSON STREET, JERSEY CITY
Name
Employee
10,000
Name
Twitter
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
OGN's Discussions on Twitter

Compare OGN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
OGN
Organon Co
10.24 2.76B 6.29B 750.00M 586.00M 2.88
Drug Manufacturers - General icon
LLY
Lilly Eli Co
845.72 756.28B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
189.69 454.91B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
231.24 411.31B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
132.31 254.66B 53.40B 13.68B 16.89B 6.8864
Drug Manufacturers - General icon
MRK
Merck Co Inc
86.40 218.83B 63.43B 16.42B 14.72B 6.4861

Organon Co Stock (OGN) Upgrades & Downgrades

Date Action Analyst Rating Change
May-02-25 Downgrade Evercore ISI Outperform → In-line
Sep-06-24 Downgrade JP Morgan Neutral → Underweight
Nov-03-23 Downgrade Goldman Buy → Neutral
Sep-21-23 Initiated Barclays Overweight
Mar-16-23 Initiated Raymond James Outperform
Oct-14-22 Downgrade BofA Securities Neutral → Underperform
Sep-06-22 Upgrade Piper Sandler Neutral → Overweight
Aug-05-22 Downgrade BofA Securities Buy → Neutral
Apr-27-22 Initiated Goldman Buy
Apr-06-22 Resumed Morgan Stanley Equal-Weight
Oct-07-21 Initiated Piper Sandler Neutral
Sep-01-21 Initiated BofA Securities Buy
Jul-22-21 Initiated Citigroup Buy
Jun-15-21 Initiated JP Morgan Neutral
Jun-11-21 Initiated Morgan Stanley Equal-Weight
Jun-10-21 Initiated Evercore ISI Outperform
View All

Organon Co Stock (OGN) Latest News

pulisher
09:00 AM

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance

09:00 AM
pulisher
08:41 AM

Is Organon a Hidden Bargain After Shares Drop Nearly 40% in 2024? - simplywall.st

08:41 AM
pulisher
Oct 06, 2025

Organon (OGN) Stock Slides as Market Rises: Facts to Know Before You Trade - sharewise.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report? - sharewise.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Organon (NYSE:OGN) A Risky Investment? - 富途牛牛

Oct 06, 2025
pulisher
Oct 06, 2025

Is Organon Co a good long term investmentInterest Rate Changes & Advanced Stock Screening Tools - earlytimes.in

Oct 06, 2025
pulisher
Oct 06, 2025

3 Reasons To Avoid OGN And 1 Stock To Buy Instead - Barchart.com

Oct 06, 2025
pulisher
Oct 06, 2025

3 Reasons to Avoid OGN and 1 Stock to Buy Instead - FinancialContent

Oct 06, 2025
pulisher
Oct 05, 2025

Organon & Co trades in the red for seven straight sessions - MSN

Oct 05, 2025
pulisher
Oct 03, 2025

Organon & Co. (NYSE:OGN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Co. (7XP) stock good for long term investingJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Organon & Co. $OGN Shares Acquired by Cantor Fitzgerald Investment Advisors L.P. - MarketBeat

Oct 02, 2025
pulisher
Oct 01, 2025

Organon & Co. $OGN Shares Purchased by State of Alaska Department of Revenue - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know - Yahoo

Sep 30, 2025
pulisher
Sep 30, 2025

Co. (7XP) stock in 2025Quarterly Profit Review & Community Driven Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Organon & Co. $OGN Stake Lessened by Sound Income Strategies LLC - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Dakota Wealth Management Has $151,000 Stock Position in Organon & Co. $OGN - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Co. (7XP) stock considered safe havenPortfolio Return Report & AI Enhanced Execution Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Organon (OGN) Outperforms Broader Market: What You Need to Know - sharewise.com

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Organon Co stockReal-Time Stock Alerts & High Return Stock Ideas - Early Times

Sep 28, 2025
pulisher
Sep 28, 2025

Sterneck Capital Management LLC Makes New Investment in Organon & Co. $OGN - MarketBeat

Sep 28, 2025
pulisher
Sep 27, 2025

Register Financial Advisors LLC Sells 30,706 Shares of Organon & Co. $OGN - MarketBeat

Sep 27, 2025
pulisher
Sep 26, 2025

Organon partners across Asia Pacific to push equitable access to contraception ahead of World Contraception Day - MediaBrief

Sep 26, 2025
pulisher
Sep 25, 2025

Here's Why Organon (OGN) Fell More Than Broader Market - sharewise.com

Sep 25, 2025
pulisher
Sep 24, 2025

Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - sharewise.com

Sep 24, 2025
pulisher
Sep 24, 2025

Organon & Co. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Sep 24, 2025
pulisher
Sep 22, 2025

Wedmont Private Capital Acquires 106,561 Shares of Organon & Co. $OGN - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Organon (OGN): Examining Valuation Following European Approval of Denosumab Biosimilars - simplywall.st

Sep 22, 2025
pulisher
Sep 21, 2025

Organon announces departure of chief commercial officer - MSN

Sep 21, 2025
pulisher
Sep 21, 2025

Gilman Hill Asset Management LLC Sells 443,231 Shares of Organon & Co. $OGN - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Triumph Capital Management Acquires 47,127 Shares of Organon & Co. $OGN - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Organon (OGN) Stock Dips While Market Gains: Key Facts - sharewise.com

Sep 20, 2025
pulisher
Sep 19, 2025

Organon gets EU approval for Prolia and Xgeva biosimilars - MSN

Sep 19, 2025
pulisher
Sep 19, 2025

Douglas Lane & Associates LLC Raises Holdings in Organon & Co. $OGN - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Organon Q2 Preview: What to expect? - MSN

Sep 19, 2025
pulisher
Sep 19, 2025

Ocugen gets EU approval for Prolia and Xgeva biosimilars - MSN

Sep 19, 2025
pulisher
Sep 19, 2025

Organon (OGN) Gains EU Approval for Denosumab Biosimilars - GuruFocus

Sep 19, 2025
pulisher
Sep 19, 2025

Organon gets EU approval for Prolia and Xgeva biosimilars (OGN:NYSE) - Seeking Alpha

Sep 19, 2025
pulisher
Sep 19, 2025

Organon, Shanghai Henlius: EC approves marketing for Bildyos, Bilprevda - TipRanks

Sep 19, 2025
pulisher
Sep 19, 2025

(denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively - Business Wire

Sep 19, 2025
pulisher
Sep 18, 2025

Belpointe Asset Management LLC Buys New Stake in Organon & Co. $OGN - MarketBeat

Sep 18, 2025
pulisher
Sep 17, 2025

Is Cognition Therapeutics Inc. stock heavily shortedMarket Performance Recap & Reliable Trade Execution Plans - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

WBI Investments LLC Purchases New Stake in Organon & Co. $OGN - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Profit Recap: Should I buy Organon Co stock nowGDP Growth & Low Risk High Win Rate Picks - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Organon & Co. (OGN) Wins FDA Nod for Biosimilars to Prolia and Xgeva - Insider Monkey

Sep 16, 2025
pulisher
Sep 16, 2025

Downgrade Watch: Can Organon & Co. deliver consistent dividendsPortfolio Return Summary & Weekly Top Stock Performers List - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Amundi Purchases 102,715 Shares of Organon & Co. $OGN - MarketBeat

Sep 16, 2025

Organon Co Stock (OGN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Organon Co Stock (OGN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
COX CARRIE SMITH
Director
May 14 '25
Buy
8.07
12,469
100,591
12,469
Falcione Aaron
Chief Human Resources Officer
May 07 '25
Buy
8.77
5,500
48,235
62,974
Weaver Kirke
Gen. Counsel & Corp. Secy.
May 06 '25
Buy
9.21
8,045
74,054
52,489
Karp Daniel
Executive VP, Corp. Dev.
May 06 '25
Buy
8.24
3,500
28,828
46,669
WALSH MATTHEW M
Chief Financial Officer
May 05 '25
Buy
8.82
11,400
100,548
144,484
Ali Kevin
Chief Executive Officer
May 05 '25
Buy
8.80
34,000
299,370
282,731
Falcione Aaron
Chief Human Resources Officer
Mar 31 '25
Option Exercise
0.00
18,732
0
59,237
Karp Daniel
Executive VP, Corp. Dev.
Mar 31 '25
Option Exercise
0.00
34,677
0
44,515
Stahler Rachel A
Chief Information Officer
Mar 31 '25
Option Exercise
0.00
18,334
0
78,994
WALSH MATTHEW M
Chief Financial Officer
Mar 31 '25
Option Exercise
0.00
34,870
0
136,903
drug_manufacturers_general SNY
$48.80
price down icon 0.80%
drug_manufacturers_general PFE
$25.68
price down icon 2.25%
$118.25
price up icon 1.26%
$294.62
price down icon 0.31%
drug_manufacturers_general NVO
$59.61
price up icon 1.00%
drug_manufacturers_general MRK
$86.40
price down icon 1.38%
Cap:     |  Volume (24h):